Regulatory Nebilet PMS

NCT01077661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 743

Last updated 2017-05-30

No results posted yet for this study

Summary

An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of Nebivolol administered in Korean patients according to the prescribing information

Conditions

Interventions

DRUG

Nebivolol

patients administrated Nebivolol according to the prescribing information

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077661 on ClinicalTrials.gov